Resumo do NICE

As recomendações neste tópico do Best Practice são baseadas em diretrizes internacionais autorizadas, complementadas por evidências e opiniões de especialistas relevantes para a prática recentes. Para seu maior benefício resumimos abaixo as principais recomendações das diretrizes do NICE relevantes.

Principais recomendações do NICE sobre diagnóstico

This summary covers post-traumatic stress disorder in adults (aged 18 years and over).

Ask people specific questions about re‑experiencing, avoidance, hyperarousal (including hypervigilance, anger, irritability), dissociation, negative alterations in mood and thinking, and associated functional impairment when assessing for post-traumatic stress disorder (PTSD).

People with PTSD (or complex PTSD) may present with a range of symptoms (associated with functional impairment) including those mentioned above, and:

  • Emotional numbing

  • Emotional dysregulation

  • Interpersonal difficulties or problems in relationships

  • Negative self-perception (including feeling diminished, defeated or worthless).

Ask people with symptoms, and consider asking people with unexplained physical symptoms who repeatedly attend health services, if they have experienced 1 or more traumatic events (which could be experiencing or witnessing single, repeated or multiple events, and may have occurred many months or years before). Give specific examples:

  • Serious accidents

  • Physical and sexual assault

  • Abuse (including childhood or domestic)

  • Work-related exposure to trauma (including remote exposure)

  • Trauma related to serious health problems or childbirth experiences (e.g., intensive care admission or neonatal death)

  • War and conflict (e.g., combat-related trauma [i.e., traumatic incidents associated with military combat])

  • Torture.

Comprehensively assess people presenting with clinically important symptoms of PTSD (i.e., those assessed as having PTSD on a validated scale, but who do not necessarily have a diagnosis of PTSD), including assessment of physical and psychosocial needs, and risk.

  • Coordinate the person's care and determine the need for emergency physical or mental health assessment.

Consider the impact of the traumatic event on other family members. If any are suspected to also have PTSD, consider further assessment.

Consider routine use of a validated, brief PTSD screening tool as part of any comprehensive physical and mental health screen for refugees and asylum seekers at high risk of PTSD.

Pay particular attention to identifying people with PTSD in working/living environments where there may be cultural challenges to recognising the psychological consequences of trauma.

Link para a orientação do NICE

Post-traumatic stress disorder (NG116) December 2018. https://www.nice.org.uk/guidance/ng116

Principais recomendações do NICE sobre tratamento

Please be aware that some of the following indications for medications may not be licensed by the manufacturer (i.e., the use of the medication is ‘off-label’). Refer to the full NICE guideline and your local drug formulary for further information when prescribing.

This summary covers post-traumatic stress disorder in adults (aged 18 years and over).

Establish a risk management and safety plan as part of initial treatment planning if the person with PTSD is identified to be at a significant risk of harm to themselves or others.

Be aware of the risk of continued exposure to trauma-inducing environments. Avoid exposing people to triggers that could worsen symptoms or stop engagement with treatment (e.g., noisy or restricted environments, use of restraint).

Consider social or personal factors that may have a role in the development or maintenance of PTSD (e.g., childhood maltreatment, multiple traumatic events).

If multiple family members have PTSD after experiencing the same traumatic event, consider what aspects of treatment might be usefully provided together (e.g., psychoeducation), alongside individual treatments.

Consider active monitoring for people with subthreshold symptoms of PTSD within 1 month of a traumatic event. Arrange follow-up contact to take place within 1 month.

Psychological interventions for prevention and treatment of PTSD in adults

A choice of therapist should be offered, considering the person’s trauma experience (e.g., they may prefer a specific gender of therapist).

Do not offer psychologically-focused debriefing for the prevention or treatment of PTSD.

An individual trauma-focused cognitive behavioural therapy (CBT) intervention should be offered to prevent PTSD in adults who have acute stress disorder (i.e., a DSM-5 diagnosis that applies in the first month after a traumatic event, and requires symptoms to meet specified criteria) or clinically important symptoms of PTSD and have been exposed to 1 or more traumatic events within the last month. Individual trauma-focused CBT interventions include:

  • Cognitive processing therapy

  • Cognitive therapy for PTSD

  • Narrative exposure therapy

  • Prolonged exposure therapy.

An individual trauma-focused CBT intervention should be offered to adults with a diagnosis of PTSD or clinically important symptoms of PTSD who have presented more than 1 month after a traumatic event.

Eye movement desensitisation and reprocessing (EMDR) should be considered for adults with a diagnosis of PTSD or clinically important symptoms of PTSD who have presented between 1 and 3 months after a non-combat-related trauma if they have a preference for EMDR.

For adults with a diagnosis of PTSD or clinically important symptoms of PTSD who have presented more than 3 months after a traumatic event:

  • EMDR should be offered if the trauma experienced was non-combat-related

  • Supported trauma-focused computerised CBT should be considered if the person prefers it to face-to-face trauma-focused CBT or EMDR, as long as they do not have severe PTSD symptoms (in particular dissociative symptoms) and they are not at risk of harm to themselves or others

  • CBT interventions targeted at specific symptoms (e.g., sleep disturbance or anger) should only be considered if the person is unable or unwilling to engage in a trauma-focused intervention or they have residual symptoms after a trauma-focused intervention.

Drug treatments for adults

Do not offer drug treatments (including benzodiazepines) to prevent PTSD in adults.

For adults with a diagnosis of PTSD, consider:

  • Venlafaxine or a selective serotonin-reuptake inhibitor (e.g., sertraline) if the person has a preference for drug treatment. Review this treatment regularly

  • Antipsychotics (e.g., risperidone) in addition to psychological therapies to manage disabling symptoms and behaviours (e.g., severe hyperarousal or psychotic symptoms) which have not responded to other drug or psychological treatments. Antipsychotic treatment should be started and reviewed regularly by a specialist.

Care for people with PTSD and complex needs

For people presenting with PTSD and depression, PTSD should usually be treated first because depression will often improve with successful PTSD treatment. However, depression should be treated first if it is severe enough to make psychological treatment of PTSD difficult, or if there is a risk of the person harming themselves or others.

Do not exclude people with PTSD from treatment based solely on comorbid drug or alcohol misuse.

For people with additional needs (including those with complex PTSD):

  • Build in extra time to develop trust (e.g., increase duration/number of therapy sessions)

  • Consider the safety and stability of their personal circumstances (e.g., housing), and how this might affect engagement and success of treatment

  • Help them to manage barriers to engagement (e.g., substance misuse, dissociation, emotional dysregulation, interpersonal difficulties, negative self-perception)

  • Plan ongoing support if needed (e.g., for residual PTSD symptoms or comorbidities).

© NICE (2018) All rights reserved. Subject to Notice of rights NICE guidance is prepared for the National Health Service in England https://www.nice.org.uk/terms-and-conditions#notice-of-rights . All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

Link para a orientação do NICE

Post-traumatic stress disorder (NG116) December 2018. https://www.nice.org.uk/guidance/ng116

O uso deste conteúdo está sujeito ao nosso aviso legal